StonvexLoading…
StonvexStonvexStonvexCore line items from NABL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $511.43M | $466.15M | $421.88M | $371.77M |
Operating Income | $36.79M | $82.37M | $70.32M | $47.40M |
Net Income | $-17.03M | $30.96M | $23.41M | $16.71M |
EPS (Diluted) | $-0.09 | $0.16 | $0.13 | $0.09 |
Total Assets | $1.41B | $1.34B | $1.16B | $1.08B |
Total Liabilities | $605.25M | $579.56M | $451.43M | $436.79M |
Cash & Equivalents | $111.84M | $85.20M | $153.05M | $98.85M |
Free Cash Flow OCF − CapEx | $75.06M | $61.87M | $76.31M | $58.58M |
Shares Outstanding | 186.68M | 187.53M | 183.22M | 180.85M |